Plain-English translation of NCT04467333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry — a collection of medical information — designed to help doctors understand how often pulmonary hypertension (high pressure in the blood vessels of the lungs) occurs in patients with lung cancer. Researchers at the University of Giessen will gather data from all lung cancer patients treated at their hospital and look for signs of this heart complication. No new treatments are being tested; instead, the study uses information collected during your regular cancer care.
Doctors want to know how common heart pressure problems are in lung cancer patients and how these two conditions affect each other. Understanding this connection could help doctors better care for lung cancer patients who may also have this heart complication.
You likely qualify if…
You likely don't qualify if…
You would not receive any new treatment or medication. Instead, your medical information collected during your regular lung cancer care at the hospital would be added to a research database. Doctors would review your records to see if you show any signs of high lung blood pressure. This happens alongside your normal visits and treatments — there are no extra appointments or procedures required.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Germany
Enrollment target
~500 participants
Started
June 2020
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bastian Eul, MD
JLU Giessen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.